The most commonly reported side effects of GLP-1 RAs are gastrointestinal, with 10% to 50% of patients experiencing nausea, vomiting, and diarrhea
Abbreviations AD: Alzheimers disease BBB: bloodbrain barrier GLP-1: glucagon-like peptide-1 GLP-1R(s): GLP-1 receptor(s) GLP-1RA(s): GLP-1 receptor agonists NDD: neurodegenerative diseases PD: Parkinsons disease T2DM: type 2 diabetes mellitus REFERENCES Knudsen LB, Lau J (2019) The Discovery and Development of Liraglutide and Semaglutide
If the bottle is open for too long, it might affect the stability of the product
Boehringer Ingelheim describes it as a dual glucagon/GLP1 receptor agonist that has the potential to address obesity while also supporting liver function, a key regulator of metabolic health. The company links the waistcircumference reduction in SYNCHRONIZE1 to effects on visceral fat, noting that excess visceral fat, particularly abdominal, is a known contributor to metabolic dysfunction and closely connected to impaired liver function
Serum beta-hydroxybutyrate level increased steadily during his admission, representing adherence with the protocol
This dual action makes it particularly effective for those with low growth hormone levels who struggle to maintain or build muscle mass